STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market

Zimmermann Spring 2027 Ready-to-Wear

STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and mor…

Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition wi…

Hot vs. Cold Exposure: Which Is Better for Muscle Recovery?

Here’s everything you need to know to create a post-workout routine that will help you feel rested and renewed, accordin…